Treatment of allograft rejection with IL-2 receptor-specific cyt
Treatment of tumors of the central nervous system with immunotox
TXU-5/B53-PAP antiviral biotherapeutic agent for the treatment o
Use of autoantibodies for tumor therapy and prophylaxis
Use of autoantibodies for tumor therapy and prophylaxis
VEGF-gelonin for targeting the vasculature of solid tumors